Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : HAXS - Health Axis -- Ignore unavailable to you. Want to Upgrade?

To: Don Hand who wrote (62)	8/16/2000 3:27:54 PM
From: Don Hand	Read Replies (1) \| Respond to of 124

Stephens retains BUY as of yesterday 8/15/2000 This report has been prepared solely for informative purposes and is not a solicitation, or an offer, to buy or sell any security. It does not purport to be a complete description of the securities, markets or developments referred to in the material. All expressions of opinion are subject to change without notice. The information is obtained from internal and external sources which we consider reliable but we have not independently verified such information and we do not guarantee that it is accurate or complete. We do not undertake to advise you to any change in figures or our views. We, our employees, and/or our officers and directors, may from time to time have a long or short position in the securities mentioned and may sell or buy such securities. Additional information available upon request. Stephens Inc., 111 Center Street, Little Rock, Arkansas 72201, (501) 374-4361, FAX (501) 377-2666, Member NYSE, NASD, SIPC Stephens Inc. Research Bulletin August 15, 2000 HEALTHAXIS FYDec. Rev (mil.) Prior Est. HAXS – $3.00 Rating: BUY 99A $43.0 Price Target (12 mo.): $15 00E U.R.* N.C. Nik Fisken, CFA, Analyst (501) 377-6335 01E U.R. N.C. Barry McCarver, Associate, (501) 377-8131 * Under review 2Q00 Results Summary. HealthAxis made numerous announcements yesterday along with 2Q00 results. Altogether, we believe the announcements will result in further downward price pressure, and we don’t expect investor sentiment to improve until HAXS announces a significant new customer. Management noted that its new customer pipeline continues to grow, but this has been the case for quite some time. We are maintaining our BUY rating based on our assumption that new customers will be announced over the next year and that HAXS has plenty of cash to get to that point. In the meantime, we expect continued volatility for the common. It is important to point out that the lack of carrier signings is an industry-wide issue and not a company-specific problem, since no competitors appear to be signing contracts. New Merger Information. Due to HAXS’ depressed price levels for the past several weeks, the exchange ratio for the merger between HealthAxis Inc. and HealthAxis.com is currently being evaluated for adjustment from an exchange of 1.12 to 1 to a range of 1.37 - 1.3 to 1. If the ratio were adjusted, it would be dilutive to HAXS shareholders. 2Q00 Results. Sales for the quarter were $10.4 million. Before suspending our estimates due to the company’s reorganization, we forecast $12.2 million in sales. EPS came in at ($0.35), excluding one-time charges. In conjunction with the sale of its retail Web site to Digital Insurance, HAXS wrote down $255.8 million in goodwill as a discontinued operation. The Company expects that its cash burn rate for the last half of the year will total approximately $9 million. As of June 30, HAXS had $31.5 million in cash and marketable securities. Stephens Inc. maintains a market in the common stock of HealthAxis Inc. and may act as principal in these transactions. Stephens Inc. has acted as private placement agent for HealthAxis Inc. LTM=last 12 months; NTM=next 12 months; STM=second 12 months BUY—one-year price appreciation expected to be greater than 20%; MARKET OUTPERFORMER—one-year price appreciation expected to be between 10% and 20%; NEUTRAL—one-year price appreciation expected to be less than 10%; SELL—whenever warranted.